{
    "2018-04-19": [
        [
            {
                "time": "",
                "original_text": "药明康德在美国扩建的测试事业部基地正式投入运营",
                "features": {
                    "keywords": [
                        "药明康德",
                        "美国",
                        "扩建",
                        "测试事业部",
                        "基地",
                        "投入运营"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德：在美国新泽西州扩建研发基地 提升药物研发测试服务能力",
                "features": {
                    "keywords": [
                        "药明康德",
                        "美国",
                        "新泽西州",
                        "扩建",
                        "研发基地",
                        "提升",
                        "服务能力"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德募资堪比抽水机的功率 这事该怎么看？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "募资",
                        "抽水机",
                        "功率"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "603259药明康德|新股药明康德申购详情",
                "features": {
                    "keywords": [
                        "603259",
                        "药明康德",
                        "新股",
                        "申购"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "证券研究院|一文读懂“医药独角兽”药明康德招股意向书",
                "features": {
                    "keywords": [
                        "证券研究院",
                        "医药独角兽",
                        "药明康德",
                        "招股意向书"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "杜坤维:单纯限制IPO首募资金不是一个好方式",
                "features": {
                    "keywords": [
                        "杜坤维",
                        "IPO",
                        "首募资金",
                        "限制",
                        "方式"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}